Chronic kidney disease and eventual kidney failure are incurable diseases that affect 13% of the U.S. population, particularly those with high blood pressure and diabetes. These diseases degrade the "podocyte" cells of the ...
Aug 31, 2022
0
50
King's researchers have found an innovative approach for expanding and maturing innate immune cells in a dish.
Aug 31, 2022
0
51
A stretch of DNA that hops around the human genome plays a role in premature aging disorders, scientists at the Salk Institute and King Abdullah University of Science and Technology (KAUST) in Saudi Arabia have discovered. ...
Aug 10, 2022
0
93
Researchers at the University of California San Diego and the Salk Institute for Biological Studies have developed a tiny neural probe that can be implanted for longer time periods to record and stimulate neural activity, ...
Jun 9, 2022
0
89
A simple addition to injected COVID-19 vaccines could enhance their effectiveness and provide "border protection" immunity in areas like the nose and mouth to supplement antibodies in the bloodstream, new research suggests.
Aug 11, 2021
0
382
In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
May 26, 2021
0
326
Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary pancreatitis have a 40 to 50 percent lifetime risk of developing ...
Jun 20, 2019
0
1
PITTSBURGH (February 15, 2019) ... Neural stimulation is a developing technology that has beneficial therapeutic effects in neurological disorders, such as Parkinson's disease. While many advancements have been made, the ...
Feb 15, 2019
0
597
Biomedical engineers have developed a smartphone app for the non-invasive detection of anemia. Instead of a blood test, the app uses photos of someone's fingernails taken on a smartphone to accurately measure how much hemoglobin ...
Dec 4, 2018
1
188
Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.
Mar 28, 2024
0
1
